Mizushima Y, Kashii T, Kobayashi M
First Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Japan.
Anticancer Res. 1995 Jan-Feb;15(1):37-43.
Effect of N-myc antisense oligodeoxynucleotide (ODN) on the proliferation of tumor cells and its combined antitumor effect with cisplatin were examined in vitro on human lung cancer cell lines with N-myc amplification. The N-myc oligomer containing the sequence complementary to the ATG initiation codon exhibited a stronger antiproliferative effect on tumor cells than did the oligomer not containing the sequence. A significant difference in the anti-proliferative effect between antisense ODN and sense ODN treatment was observed only on tumor cells with N-myc amplification. Pretreatment with antisense ODN showed a tendency to reduce rather than enhance cisplatin cytotoxicity. Posttreatment with antisense ODN also showed no beneficial effects on cisplatin cytotoxicity. This study suggests that pretreatment with antisense ODN may not be beneficial when combined with chemotherapy.
在体外对具有N - myc扩增的人肺癌细胞系,研究了N - myc反义寡脱氧核苷酸(ODN)对肿瘤细胞增殖的影响及其与顺铂联合的抗肿瘤作用。与不包含该序列的寡聚物相比,含有与ATG起始密码子互补序列的N - myc寡聚物对肿瘤细胞表现出更强的抗增殖作用。仅在具有N - myc扩增的肿瘤细胞上观察到反义ODN与正义ODN处理之间抗增殖作用的显著差异。用反义ODN预处理显示出降低而非增强顺铂细胞毒性的趋势。用反义ODN后处理对顺铂细胞毒性也没有有益作用。本研究表明,反义ODN与化疗联合使用时,预处理可能并无益处。